Editorial to the Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF Japan): One‐year safety and effectiveness analyses

Lignende værker

• Safety and effectiveness of edoxaban in Japanese patients with nonvalvular atrial fibrillation: Final report of a two‐year postmarketing surveillance study (ETNA‐AF‐Japan)
  af: Takeshi Yamashita, et al.
  Udgivet: (2021-04-01)
• Postmarketing surveillance on clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF‐Japan): Three‐month interim analysis results
  af: Takeshi Yamashita, et al.
  Udgivet: (2019-02-01)
• Effectiveness and safety of edoxaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies
  af: Mohammed M. Alsultan, et al.
  Udgivet: (2023-11-01)
• Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
  af: Alexander T. Cohen, et al.
  Udgivet: (2018-05-01)
• Gallbladder hemorrhage during orally administered edoxaban therapy: a case report
  af: Hideya Itagaki, et al.
  Udgivet: (2019-12-01)